Launspach M, Temel D, Ohlendorf E, Zirngibl F, Materne B, Oevermann L, Deubzer HE, Henssen AG, Künkele A, Hundsdörfer P, Bernuth H von, Pruß A, Eggert A, Stackelberg A von, Lang P, Schulte JH. Rituximab therapy after pediatric hematopoietic stem cell transplantation can cause prolonged B-cell impairment and increases the risk for infections - a retrospective matched cohort study. haematol [Internet]. 2023Jan.1 [cited 2024Nov.23];108(1):267-72. Available from: https://haematologica.org/article/view/haematol.2022.281134